Medication Summary

Topical, oral, or intralesional corticosteroids are used in the treatment of ocular juvenile xanthogranuloma (JXG). Because of risk of spontaneous hemorrhage, all ocular tumors probably should be treated.^[13]Specific medications used include the treatments described below.

Class Summary

Minimize the activity of inflammatory cells and formation of granulomas. Used in symptomatic patients and commonly provides symptomatic improvement.

Prednisolone acetate 1% (Pred Forte)

View full drug information

Decreases inflammation by suppressing migration of polymorphonuclear leukocytes and reversing increased capillary permeability. DOC for lesions involving the anterior segment.

Prednisolone ophthalmic (Delta-Cortef, Econopred)

View full drug information

Decreases inflammation by suppressing migration of polymorphonuclear leukocytes and reversing increased capillary permeability. For ocular lesions not responsive to topical steroids.

Dexamethasone ophthalmic (Maxidex)

View full drug information

Questions

Strehl JD, Stachel KD, Hartmann A, Agaimy A. Juvenile xanthogranuloma developing after treatment of Langerhans cell histiocytosis: case report and literature review. Int J Clin Exp Pathol. 2012. 5(7):720-5. [Medline]. [Full Text].
Cypel TK, Zuker RM. Juvenile xanthogranuloma: Case report and review of the literature. Can J Plast Surg. 2008 Fall. 16(3):175-7. [Medline]. [Full Text].
Kim MS, Kim SA, Sa HS. Old-age-onset subconjunctival juvenile xanthogranuloma without limbal involvement. BMC Ophthalmol. 2014 Mar 6. 14:24. [Medline]. [Full Text].
Liang S, Liu YH, Fang K. Juvenile xanthogranuloma with ocular involvement. Pediatr Dermatol. 2009 Mar-Apr. 26(2):232-4. [Medline].
Karcioglu ZA, Mullaney PB. Diagnosis and management of iris juvenile xanthogranuloma. J Pediatr Ophthalmol Strabismus. 1997 Jan-Feb. 34(1):44-51. [Medline].
Vendal Z, Walton D, Chen T. Glaucoma in juvenile xanthogranuloma. Semin Ophthalmol. 2006 Jul-Sep. 21(3):191-4. [Medline].
Lau HH, Yip WW, Lee A, Lai C, Fan DS. Three different ophthalmic presentations of juvenile xanthogranuloma. Hong Kong Med J. 2014 Jun. 20(3):261-3. [Medline].
Cambiaghi S, Restano L, Caputo R. Juvenile xanthogranuloma associated wiht neurofibromatosis 1: patients without evidence of hematologic malignancies. Pediatr Dermatol. 2004. 21(2):97-101. [Medline].
Chu MW, Werner A, Moody-Antonio SA. Juvenile xanthogranuloma of the tympanic membrane: A case report. Ear Nose Throat J. 2012 Sep. 91(9):364-8. [Medline].
Meshkini A, Shahzadi S, Zali A, Tajeddini A, Mirzayan J, Hamdi A. Systemic juvenile xanthogranuloma with multiple central nervous system lesions. J Cancer Res Ther. 2012 Apr-Jun. 8(2):311-3. [Medline].
Shields CL, Thaler AS, Lally SE, Lin CJ, Trachtman MS, Eagle RC Jr, et al. Massive macronodular juvenile xanthogranuloma of the eyelid in a newborn. J AAPOS. 2014 Apr. 18(2):195-7. [Medline].
Kontos G, Borooah S, Khan A, Fleck BW, Coupland SE. The epidemiology, clinical characteristics, histopathology and management of juvenile- and adult-onset corneoscleral limbus xanthogranuloma. Graefes Arch Clin Exp Ophthalmol. 2016 Mar. 254 (3):413-20. [Medline].
Samara WA, Khoo CT, Say EA, Saktanasate J, Eagle RC Jr, Shields JA, et al. Juvenile Xanthogranuloma Involving the Eye and Ocular Adnexa: Tumor Control, Visual Outcomes, and Globe Salvage in 30 Patients. Ophthalmology. Oct 2015. 122(10):2130-8. [Medline].
Cadera W, Silver MM, Burt L. Juvenile xanthogranuloma. Can J Ophthalmol. 1983 Jun. 18(4):169-74. [Medline].
Chang MW. Update on juvenile xanthogranuloma: unusual cutaneous and systemic variants. Semin Cutan Med Surg. 1999 Sep. 18(3):195-205. [Medline].
DeBarge LR, Chan CC, Greenberg SC, et al. Chorioretinal, iris, and ciliary body infiltration by juvenile xanthogranuloma masquerading as uveitis. Surv Ophthalmol. 1994 Jul-Aug. 39(1):65-71. [Medline].
Harley RD, Romayananda N, Chan GH. Juvenile xanthogranuloma. J Pediatr Ophthalmol Strabismus. 1982 Jan-Feb. 19(1):33-9. [Medline].
Hernandez-Martin A, Baselga E, Drolet BA, Esterly NB. Juvenile xanthogranuloma. J Am Acad Dermatol. 1997 Mar. 36(3 Pt 1):355-67; quiz 368-9. [Medline].
Kaur H, Cameron JD, Mohney BG. Severe astigmatic amblyopia secondary to subcutaneous juvenile xanthogranuloma of the eyelid. J AAPOS. 2006 Jun. 10(3):277-8. [Medline].
Miszkiel KA, Sohaib SA, Rose GE, et al. Radiological and clinicopathological features of orbital xanthogranuloma. Br J Ophthalmol. 2000 Mar. 84(3):251-8. [Medline].
Shields JA, Shields CL. Clinical spectrum of histiocytic tumors of the orbit. Trans Pa Acad Ophthalmol Otolaryngol. 1990. 42:931-7. [Medline].
Tanz WS, Schwartz RA, Janniger CK. Juvenile xanthogranuloma. Cutis. 1994 Oct. 54(4):241-5. [Medline].
Weitzman S, Jaffe R. Uncommon histiocytic disorders: The non-Langerhans cell histiocytoses. Pediatr Blood Cancer. 2005. 44:1-9. [Medline].
Zvulunov A, Barak Y, Metzker A. Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia. World statistical analysis. Arch Dermatol. 1995 Aug. 131(8):904-8. [Medline].

Media Gallery

Juvenile xanthogranuloma. Photograph of an 18-month-old presenting with a firm, nodular, tan-yellow lesion that has grown since first noticed 6 months ago. An examination under anesthesia did not reveal any ocular abnormalities. Excision of the lesion confirmed that this was a juvenile xanthogranuloma.
Touton giant cell in juvenile xanthogranuloma. Touton giant cell with a wreath of nuclei surrounding a homogenous eosinophilic cytoplasmic center in juvenile xanthogranuloma. Touton cells are named after Karl Touton, who first described them in 1885. Touton giant cells are seen in xanthoma, juvenile and adult xanthogranulomas, dermatofibroma, and fat necrosis.

of 2

Author

Bhupendra C K Patel, MD, FRCS Professor of Ophthalmic Plastic and Facial Cosmetic Surgery, Department of Ophthalmology and Visual Sciences, John A Moran Eye Center, University of Utah School of Medicine

Bhupendra C K Patel, MD, FRCS is a member of the following medical societies: American Academy of Ophthalmology, American Society of Ophthalmic Plastic and Reconstructive Surgery, Royal College of Surgeons of England, Royal Society of Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Simon K Law, MD, PharmD Clinical Professor of Health Sciences, Department of Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles, David Geffen School of Medicine

Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology, American Glaucoma Society

Disclosure: Nothing to disclose.

J James Rowsey, MD Former Director of Corneal Services, St Luke's Cataract and Laser Institute

J James Rowsey, MD is a member of the following medical societies: American Academy of Ophthalmology, American Association for the Advancement of Science, American Medical Association, Association for Research in Vision and Ophthalmology, Florida Medical Association, Sigma Xi, The Scientific Research Honor Society, Southern Medical Association, Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

Chief Editor

Michael Taravella, MD Director of Cornea and Refractive Surgery, Rocky Mountain Lions Eye Institute; Professor, Department of Ophthalmology, University of Colorado School of Medicine

Michael Taravella, MD is a member of the following medical societies: American Academy of Ophthalmology, American Medical Association, American Society of Cataract and Refractive Surgery, Contact Lens Association of Ophthalmologists, Eye Bank Association of America

Disclosure: Received income in an amount equal to or greater than $250 from: J&J Vision (Consultant)/Proctor<br/> for: Coronet Surgical (Consultant), no income received.

Additional Contributors

Gerhard W Cibis, MD † Clinical Professor, Director of Pediatric Ophthalmology Service, Department of Ophthalmology, University of Kansas School of Medicine

Gerhard W Cibis, MD is a member of the following medical societies: American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, American Ophthalmological Society

Disclosure: Nothing to disclose.

Acknowledgements

Theodore Curtis, MD Assistant Professor, Department of Ophthalmology, University of Colorado; Consulting Staff, Rocky Mountain Lions Eye Institute

Theodore Curtis, MD is a member of the following medical societies: American Academy of Ophthalmology and American Association for Pediatric Ophthalmology and Strabismus

Disclosure: Nothing to disclose.

David T Wheeler, MD Associate Professor, Departments of Ophthalmology and Pediatrics, Oregon Health & Science University

David T Wheeler, MD is a member of the following medical societies: American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, and Phi Beta Kappa

Disclosure: Nothing to disclose.